Open AccessMedicine

B. Simell, Kari Auranen, H. Käyhty, D. Goldblatt, R. Dagan, K. O'Brien

2012.7.1Expert Review of Vaccines

DOI: 10.1586/erv.12.53

tlooto Summary

The use of vaccine effect on carriage as part of the vaccine licensure and post-vaccine introduction evaluation could facilitate and expand the licensure of new, life-saving pneumococcal vaccines and enable a comprehensive estimate of population effects after vaccine introduction.

Abstract

Streptococcus pneumoniae (pneumococcus) is a major cause of worldwide mortality and morbidity, and to a large extent is vaccine-preventable. Nasopharyngeal carriage of pneumococcus precedes disease and is the source of pneumococcal spread between people. The use of vaccine effect on carriage as part of the vaccine licensure and post-vaccine introduction evaluation could facilitate and expand the licensure of new, life-saving pneumococcal vaccines and enable a comprehensive estimate of population effects after vaccine introduction. The authors provide a review of the evidence supporting pneumococcal carriage at the individual level as an immediate and necessary precursor to pneumococcal disease. Based on such a causal link between carriage and disease, the authors emphasize the role of information on pneumococcal carriage in vaccine trials and in public health decision-making.

Citation format

SIMELL, B., et al. The fundamental link between pneumococcal carriage and disease. Expert Review of Vaccines, 2012, 11: 841–855.